Decisions by institutional review boards (IRBs) are presumed to reflec
t the norms and standards of the scientific community. Such criteria h
ave shifted as changes have occurred in experimental interventions and
protocols, codes of federal regulatory agencies, norms among investig
ators, and expectations of participants. The tension created by shifti
ng norms and standards raises two questions: (a) Should IRBs evaluate
the scientific (e.g., design) features of the proposed research, and (
b) should consistent standards be expected even in areas that are in c
onstant flux (e.g., AIDS research)? We discuss these questions and pro
pose a mechanism to keep IRBs abreast of emergent issues and sensitize
d not only to the costs of doing research but also to the costs of not
doing it.